fda semaglutide warning november 2025 Shares in Novo Nordisk, the Danish firm best known for its Wegovy and Ozempic weight loss drugs, have plunged after it called a halt to closely-watched trials on a treatment for Alzheimer's What Patients Need to Know

When to Discuss Treatment Optimization With Your Provider A plateau does not automatically mean semaglutide is ineffective

Maternal H3K27me3 controls DNA methylation-independent imprinting

Reducing this risk is a key part of our commitment to driving change for this community, as we work to increase manufacturing capacity to responsibly supply this important medicine. The FDA decision is based on the results of the landmark SELECT phase 3 cardiovascular outcomes trial that examined the effect of adding Wegovy 2.4 mg or placebo to cardiovascular standard of care in adults with overweight and obesity with established CVD and without diabetes

To maintain peak metabolic health, we require comprehensive blood work every 12 weeks

Sterility of the otic formulation is confirmed through a sterility assurance program in accordance with United States Pharmacopeia Chapters , and

Researchers tracking full lipid panels should anticipate the most dramatic changes in the triglyceride and HDL fractions when studying higher retatrutide doses